IL142063A0 - Tetrahydropyridoether derivatives and pharmaceutical compositions containing the same - Google Patents

Tetrahydropyridoether derivatives and pharmaceutical compositions containing the same

Info

Publication number
IL142063A0
IL142063A0 IL14206399A IL14206399A IL142063A0 IL 142063 A0 IL142063 A0 IL 142063A0 IL 14206399 A IL14206399 A IL 14206399A IL 14206399 A IL14206399 A IL 14206399A IL 142063 A0 IL142063 A0 IL 142063A0
Authority
IL
Israel
Prior art keywords
tetrahydropyridoether
derivatives
same
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL14206399A
Other languages
English (en)
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of IL142063A0 publication Critical patent/IL142063A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IL14206399A 1998-09-23 1999-09-17 Tetrahydropyridoether derivatives and pharmaceutical compositions containing the same IL142063A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19843504 1998-09-23
EP98117988 1998-09-23
PCT/EP1999/006899 WO2000017200A1 (en) 1998-09-23 1999-09-17 Tetrahydropyridoethers

Publications (1)

Publication Number Publication Date
IL142063A0 true IL142063A0 (en) 2002-03-10

Family

ID=26049024

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14206399A IL142063A0 (en) 1998-09-23 1999-09-17 Tetrahydropyridoether derivatives and pharmaceutical compositions containing the same
IL142063A IL142063A (en) 1998-09-23 2001-03-18 History of 10,9,8,7 – Tetrahydro-9 – Phenyl – 8,7,3,2 – Transformed Tetra – Imidazo [2,1–H] [7,1] Neptyridine and pharmaceutical preparations containing them

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL142063A IL142063A (en) 1998-09-23 2001-03-18 History of 10,9,8,7 – Tetrahydro-9 – Phenyl – 8,7,3,2 – Transformed Tetra – Imidazo [2,1–H] [7,1] Neptyridine and pharmaceutical preparations containing them

Country Status (31)

Country Link
US (4) US6436953B1 (pl)
EP (1) EP1115725B1 (pl)
JP (1) JP4145492B2 (pl)
KR (1) KR100668400B1 (pl)
CN (2) CN1155598C (pl)
AT (1) ATE231862T1 (pl)
AU (1) AU763463B2 (pl)
BG (1) BG65195B1 (pl)
BR (1) BR9914044A (pl)
CA (1) CA2344251A1 (pl)
CZ (1) CZ292335B6 (pl)
DE (1) DE69905178T2 (pl)
DK (1) DK1115725T3 (pl)
EA (1) EA005377B1 (pl)
EE (1) EE04677B1 (pl)
ES (1) ES2191464T3 (pl)
GE (1) GEP20032926B (pl)
HK (1) HK1038360B (pl)
HR (1) HRP20010224A2 (pl)
HU (1) HUP0102990A3 (pl)
ID (1) ID28896A (pl)
IL (2) IL142063A0 (pl)
NO (1) NO317304B1 (pl)
NZ (1) NZ510610A (pl)
PL (1) PL193616B1 (pl)
PT (1) PT1115725E (pl)
RS (1) RS50145B (pl)
SI (1) SI1115725T1 (pl)
SK (1) SK285165B6 (pl)
TR (1) TR200100805T2 (pl)
WO (1) WO2000017200A1 (pl)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID28896A (id) 1998-09-23 2001-07-12 Byk Gulden Lomberg Chem Fab Tetrahidro pirido eter
ATE240956T1 (de) 1999-04-17 2003-06-15 Altana Pharma Ag Haloalkoxy-imidazonaphthyridine
CA2721484A1 (en) * 1999-05-12 2000-11-12 President And Fellows Of Harvard College Dopamine transporter imaging agents
JP2003528879A (ja) * 2000-03-29 2003-09-30 アルタナ ファルマ アクチエンゲゼルシャフト 三環式イミダゾピリジン
EP1313740B1 (en) * 2000-03-29 2005-11-30 ALTANA Pharma AG Prodrugs of imidazopyridine derivatives
BR0114873A (pt) * 2000-10-25 2003-07-01 Altana Pharma Ag Imidazopiridinas polissubstituìdas
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
WO2002069968A1 (en) * 2001-03-08 2002-09-12 Astrazeneca Ab New use
ATE336493T1 (de) 2001-08-02 2006-09-15 Altana Pharma Ag Tricyclische epoxide
KR20040023697A (ko) * 2001-08-03 2004-03-18 알타나 파마 아게 위장관계 장애의 치료를 위한 알킬 치환 이미다조피리딘
EP1417208A1 (en) * 2001-08-03 2004-05-12 ALTANA Pharma AG Amino-substituted imidazopyridines for the treatment of gastrointestinal diseases
BR0307708A (pt) 2002-02-15 2005-01-11 Altana Pharma Ag Compostos tricìclicos de n-acila
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
CN1652822A (zh) * 2002-05-07 2005-08-10 奥坦纳医药公司 用于治疗气道病症的可逆质子泵抑制剂和气道治疗剂的新组合
RS20050377A (en) 2002-11-19 2007-11-15 Altana Pharma Ag., 8-substituted imidazopyridines
PT1572217E (pt) 2002-12-12 2008-11-28 Nycomed Gmbh Medicamento combinado de r,r-formoterol e ciclesonida
WO2004056362A2 (en) * 2002-12-20 2004-07-08 Altana Pharma Ag 8-trialkysyloxy-2-methyl-9-phenyl-7-0 xo-7,8,9,10- tetrahydroimidazo ‘1,2-h! ‘1,7! naphthyridines
PL377581A1 (pl) * 2003-02-17 2006-02-06 Altana Pharma Ag Połączenia zawierające imidazopirydyny oraz ich zastosowanie do leczenia chorób zapalnych przewodu pokarmowego
ME00524B (me) 2003-03-10 2011-10-10 Astrazeneca Ab Novi postupak za dobijanje roflumilasta
TW200503783A (en) * 2003-04-11 2005-02-01 Altana Pharma Ag Oral pharmaceutical preparation for proton pump antagonists
SA04250092B1 (ar) * 2003-05-14 2008-05-04 التانا فاروا ايه جي مركب وسيط جديد لتحضير مركبات إيميدازوبيريدين imidazopyridines فعالة علاجياً
CA2526566A1 (en) * 2003-05-27 2004-12-09 Altana Pharma Ag Pharmaceutical combinations of a proton pump inhibitor and a compound which modifies gastrointestinal motility
BRPI0414046A (pt) * 2003-08-29 2006-10-24 Dynogen Pharmaceuticals Inc método de tratamento de um distúrbio de motilidade gastrintestinal, de tratamento de "gerd", de "gerd" noturno, composição farmacêutica, kit que compreende um composto e método para aumentar a motilidade esofágica em um paciente
PL1670482T5 (pl) 2003-09-16 2022-10-03 Covis Pharma Gmbh Zastosowanie cyklezonidu w leczeniu chorób układu oddechowego
CN101361738A (zh) 2003-11-03 2009-02-11 阿斯利康(瑞典)有限公司 治疗隐匿性胃食管反流的咪唑并[1,2-a]吡啶衍生物
EP1697358A1 (en) 2003-12-19 2006-09-06 Altana Pharma AG Intermediates for the preparation of tricyclic dihydropyrano -imidazo -pyridines derivatives
AR047605A1 (es) * 2004-02-17 2006-01-25 Altana Pharma Ag Imidazopiridinas triciclicas e intermediarios en la sintesis de las mismas,sus procesos de preparacion,composiciones farmaceuticas que los contienen y usos.
ES2426920T3 (es) 2004-09-03 2013-10-25 Yuhan Corporation Derivados de pirrolo[3,2-B]piridina y procesos para su preparación
AU2005280738B2 (en) 2004-09-03 2010-11-25 Yuhan Corporation Pyrrolo(3,2-c)pyridine derivatives and processes for the preparation thereof
KR100958829B1 (ko) 2004-09-03 2010-05-25 주식회사유한양행 피롤로[2,3-ｃ]피리딘 유도체 및 그의 제조방법
JP5383183B2 (ja) * 2005-03-16 2014-01-08 タケダ ゲゼルシャフト ミット ベシュレンクテル ハフツング ロフルミラストを含有する矯味された剤形
EP2080513A1 (en) 2008-01-16 2009-07-22 Schraermeyer, Ulrich, Prof. Dr. rer. nat Tetrahydropyridoethers for treatment of AMD
CN102470126A (zh) 2009-07-09 2012-05-23 拉夸里亚创药株式会社 用于治疗与异常肠胃运动有关的疾病的酸泵拮抗剂
WO2012027240A1 (en) * 2010-08-23 2012-03-01 Schering Corporation Fused tricyclic inhibitors of mammalian target of rapamycin
WO2013187727A1 (en) * 2012-06-15 2013-12-19 Bio-Pharm Solutions Co., Ltd. Phenylalkyl sulfamate compound and muscle relaxant composition comprising the same
WO2015052256A1 (en) 2013-10-08 2015-04-16 Katairo Gmbh Tetrahydropyridoethers for the treatment of stargardt's disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468400A (en) * 1982-12-20 1984-08-28 Schering Corporation Antiulcer tricyclic imidazo [1,2-a]pyridines
AU615666B2 (en) 1987-07-16 1991-10-10 Byk Gulden Lomberg Chemische Fabrik Gmbh New diazols
SE9401197D0 (sv) * 1994-04-11 1994-04-11 Astra Ab Active compounds
EP0773945A1 (de) * 1994-07-28 1997-05-21 Byk Gulden Lomberg Chemische Fabrik GmbH Acylimidazopyridine
PT971922E (pt) * 1997-03-24 2004-09-30 Altana Pharma Ag Compostos de tetra-hidropirido
EP0971922B1 (en) * 1997-03-24 2004-04-28 ALTANA Pharma AG Tetrahydropyrido compounds
ID28896A (id) 1998-09-23 2001-07-12 Byk Gulden Lomberg Chem Fab Tetrahidro pirido eter

Also Published As

Publication number Publication date
RS50145B (sr) 2009-03-25
NO20011243L (no) 2001-03-12
EE04677B1 (et) 2006-08-15
CN1319101A (zh) 2001-10-24
SK3992001A3 (en) 2001-12-03
ATE231862T1 (de) 2003-02-15
EP1115725B1 (en) 2003-01-29
WO2000017200A1 (en) 2000-03-30
HRP20010224A2 (en) 2002-04-30
DK1115725T3 (da) 2003-06-23
HK1038360B (zh) 2003-05-16
IL142063A (en) 2007-10-31
PT1115725E (pt) 2003-06-30
KR100668400B1 (ko) 2007-01-17
AU6192099A (en) 2000-04-10
CZ20011082A3 (cs) 2001-09-12
NO317304B1 (no) 2004-10-04
ES2191464T3 (es) 2003-09-01
BR9914044A (pt) 2001-12-04
BG65195B1 (bg) 2007-06-29
EE200100172A (et) 2002-06-17
CZ292335B6 (cs) 2003-09-17
ID28896A (id) 2001-07-12
US20040162310A1 (en) 2004-08-19
YU21401A (sh) 2004-03-12
CN1560055A (zh) 2005-01-05
EA200100315A1 (ru) 2001-10-22
US20020169320A1 (en) 2002-11-14
US7105676B2 (en) 2006-09-12
AU763463B2 (en) 2003-07-24
NO20011243D0 (no) 2001-03-12
US6696460B2 (en) 2004-02-24
CN100506821C (zh) 2009-07-01
PL193616B1 (pl) 2007-02-28
HUP0102990A2 (hu) 2002-01-28
TR200100805T2 (tr) 2001-08-21
HK1038360A1 (en) 2002-03-15
NZ510610A (en) 2003-07-25
BG105270A (en) 2001-11-30
PL346617A1 (en) 2002-02-25
GEP20032926B (en) 2003-03-25
KR20010075223A (ko) 2001-08-09
EA005377B1 (ru) 2005-02-24
EP1115725A1 (en) 2001-07-18
JP4145492B2 (ja) 2008-09-03
SI1115725T1 (en) 2003-06-30
US7393860B1 (en) 2008-07-01
US6436953B1 (en) 2002-08-20
HUP0102990A3 (en) 2002-09-30
DE69905178T2 (de) 2003-07-17
SK285165B6 (sk) 2006-07-07
CN1155598C (zh) 2004-06-30
JP2002526499A (ja) 2002-08-20
CA2344251A1 (en) 2000-03-30
DE69905178D1 (de) 2003-03-06

Similar Documents

Publication Publication Date Title
IL142063A0 (en) Tetrahydropyridoether derivatives and pharmaceutical compositions containing the same
HUP0200450A3 (en) Cephen derivatives containing an imidazo[4,5-b]pyridiniummethyl moiety, process for their preparation and pharmaceutical compositions of the same
HUP0104204A3 (en) Pyrazolopyridine derivatives as cox-2 inhibitors, process for their preparation and pharmaceutical compositions thereof
AU2001230892A1 (en) Orally administered pharmaceutical formulations of benzimidazole derivatives andthe method of preparing the same
HUP0203142A3 (en) Benzodiazepine derivatives, process for preparation of the compounds, pharmaceutical compositions containing them and their use
HK1031869A1 (en) 1-Ä(1-Substituted-4-piperidinyl)methylÜ-4-piperdine derivatives, process for producing the same, medicinal compositions containing the same and intermediates of these compounds.
HUP0101813A3 (en) Carboxylic acid derivatives substituted by homo- or heterocyclic group preparation method and pharmaceutical compositions containing them
EE04676B1 (et) Imidasopridiini derivaadid, mis inhibeerivad maohappesekretsiooni, protsess nende valmistamiseks ning nende kasutamine
IL136145A0 (en) Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
EP0811595A4 (en) HYDROCHALCONE DERIVATIVES, COSMETIC COMPOSITIONS CONTAINING THEM AND PROCESSES FOR PREPARING SUCH DERIVATIVES OR COMPOSITIONS
HUP0103913A3 (en) Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same
AU4949800A (en) 2-arylpurine-9-acetamide derivatives, process for the preparation thereof, medicinal compositions containing the same and intermediates of the derivatives
HUP0204157A3 (en) 1,3-dihydro-2h-indol-2-one derivatives, process for preparation of the compounds and pharmaceutical compositions containing the same
HUP9900386A3 (en) Use of phenoxy-pyridine derivatives for producing pharmaceutical compositions suitable for treating heart failure
HUP0002171A3 (en) Aminophosphonic acid derivatives, method for their preparation and pharmaceutical compositions thereof
HUP0200816A3 (en) Substituted 3-cyano-[1.7], [1.5], and [1.8]-naphthyridine inhibitors of tyrosine kinases, process for their preparation and pharmaceutical compositions containing them
IL141165A0 (en) New imidazopyridine compounds for the inhibition of acid secretion, pharmaceutical compositions thereof and process for preparing the same
EP1411056A3 (en) Imidazo[1,2-a]pyridine compounds that inhibit gastric acid secretion, pharmaceutical compositions thereof, and processes for their preparation
IL190120A0 (en) PREPARATION OF 9-AMINO OCTAHYDRO-6,10-DIOXO-6H-PYRIDAZINO/1,2-a//1,2/DIAZEPIN-1-CARBOXYLIC ACID DERIVATIVES
HUP0103004A3 (en) Substituted imidazo[1,2a]azines as selective inhibitors of cox-2, process for their preparation and pharmaceutical compositions containing them
HUP0105054A3 (en) Imidazo[4,5-c]-pyridine-4-on-derivatives, pharmaceutical compositions containing them and process for their preparation
HUP0202988A3 (en) Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one derivatives and their use as lipase inhibitors, process for their preparation and pharmaceutical compositions containing them
PL328123A1 (en) Derivatives of banzo[c]quinolysine and method of obtaining them
PL352280A1 (en) Derivatives of naphthyridine, method of making same, use of same and pharmaceutical compositions containing these derivatives
CY2392B1 (en) Method for the preparation of alpha-bromolactam derivatives.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed